HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: 2441052114v1 244/1/232    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alencar, H. Articles by Mahmood, U. Search for Related Content PubMed PubMed Citation Articles by Alencar, H. Articles by Mahmood, U.

Colonic Adenocarcinomas: Near-Infrared Microcatheter Imaging of Smart Probes for Early Detection—Study in Mice¹

¹ From the Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Bldg 149, 13th St, Room 5408, Charlestown, MA 02129. From the 2004 RSNA Annual Meeting. Received December 23, 2005; revision requested February 21, 2006; revision received June 19; accepted July 11; final version accepted November 1. Supported in part by National Institutes of Health grants RO1-EB001872, R24-CA92782, and by a grant from the Dana-Farber/Harvard Cancer Center Technology Innovation Fund. Address correspondence to U.M. (e-mail: mahmood{at}helix.mgh.harvard.edu).

Purpose: To prospectively evaluate the ability of micro-fiberoptic catheters, which simultaneously record white light and near-infrared (NIR) images, to reveal colonic neoplasms after the intravenous administration of activatable "smart" probes that increase in NIR fluorescence subsequent to protease activation.

Materials and Methods: The institutional animal care committee approved all animal experiments. CT26 tumor cells were orthotopically implanted into the descending colon of C57BL6/J mice (n = 10). Thirteen days later, mice intravenously received either 2 nmol of a protease-sensing probe that had cathepsin B as a major activator (n = 5) or saline (control animals [n = 5]). One day later, animals were noninvasively examined to the point of the splenic flexure by using microcatheter imaging. Excised colons were subsequently evaluated with epifluorescence imaging, histologic examination, and cathepsin B immunohistochemistry. Student t test was used for statistical analysis, with P < .05 considered to indicate a significant difference.

Results: Results with fiberoptic imaging demonstrated that all tumors were visible with the protease-activatable probe, even when they were not readily apparent at white light imaging. A target-to-background ratio (TBR) of 8.86 for tumor to adjacent normal mucosa was achieved in the NIR channel after probe administration (P = .001), whereas white light images resulted in a TBR of 1.14 (P > .5) based on luminosity. The tumoral NIR fluorescence intensity was more than 30-fold greater in probe-injected animals than in control animals, indicating that essentially all of the signal recorded in lesions was from activatable probe administration. Results of immunohistochemistry confirmed cathepsin B overexpression in the tumor compared with adjacent mucosa.

Conclusion: The use of NIR imaging microcatheters combined with protease-activatable smart probes results in a beacon effect that highlights tumors with high TBRs; this technique thus may be a potentially useful adjunct to white light colonoscopy in the future.

© RSNA, 2007

This article has been cited by other articles:

				M. Ogawa, C. A.S. Regino, P. L. Choyke, and H. Kobayashi In vivo target-specific activatable near-infrared optical labeling of humanized monoclonal antibodies Mol. Cancer Ther., January 1, 2009; 8(1): 232 - 239. [Abstract] [Full Text] [PDF]

				J. V. Frangioni New Technologies for Human Cancer Imaging J. Clin. Oncol., August 20, 2008; 26(24): 4012 - 4021. [Abstract] [Full Text] [PDF]